Assessing the efficacy of medical Cannabis as a substitution therapy for opioids in chronic pain management: A comprehensive investigation
Planta Medica · 01.03.2026 · 92 (03) · 382-383
DOI: 10.1055/s-0045-1815357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von S Gallow und 3 weiteren Autor:innen.
Themen: Schmerzmanagement
Abstract (Originalsprache)
The opioid epidemic has escalated as a result of over prescription, with a 41% jump in usage in 2020. On account of this, medical cannabis has emerged as a possible alternative due to its ability to decrease opiate usage and related deaths. The study aims to evaluate the effectiveness of medical cannabis in reducing opioid use and related side effects in chronic pain management. Additionally, it seeks to assess improvements in pain relief and quality of life among patients using cannabis as an adjunct therapy. The study employed a quantitative design involving data collection from 302 participants across six South African locations over twelve months. Participants were prescribed medical cannabis and monitored for changes in opioid use, pain levels, and quality of life using questionnaires and pharmacy records. Statistical analyses, including descriptive statistics and linear regression, were utilized to evaluate trends and relationships between variables. Over six months, a study of 302 participants (53.3% female, 69.2% White) found significant reductions in opioid use with medical cannabis. The research findings indicated that 72% of the participants decreased their opioid intake by a minimum of 50%, resulting in an average reduction of 93% (standard deviation=17%) by the conclusion of the study. The pain severity scores decreased from 3.4 to 3.0, and 64% of participants saw a significant improvement in pain alleviation, which was defined as a reduction of at least two rating points on the pain scale. In addition, 83.2% of the subjects reported experiencing better sleep quality, while 78.5% observed an improvement in physical function. 70.5% of participants indicated a preference for oil as the most effective form of cannabis. This particular form was found to be linked with notable enhancements in pain alleviation and quality of life across many areas. The study shows that medical cannabis can enhance pain management, sleep quality, and physical function while dramatically lowering the use of opioids. These findings indicate that it has the potential to be a feasible option in pain management approaches. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Gallow, S., Hurley, R., Jamaloodeen, A., & Katerere, D. R. (2026). Assessing the efficacy of medical Cannabis as a substitution therapy for opioids in chronic pain management: A comprehensive investigation. Planta Medica, 92(03), 382-383. https://doi.org/10.1055/s-0045-1815357
Vancouver
Gallow S, Hurley R, Jamaloodeen A, Katerere DR. Assessing the efficacy of medical Cannabis as a substitution therapy for opioids in chronic pain management: A comprehensive investigation. Planta Medica. 2026;92(03):382-383. doi:10.1055/s-0045-1815357
BibTeX
@article{Gallow2026,
author = {Gallow, S and Hurley, R and Jamaloodeen, A and Katerere, D R},
title = {Assessing the efficacy of medical Cannabis as a substitution therapy for opioids in chronic pain management: A comprehensive investigation},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {382--383},
doi = {10.1055/s-0045-1815357}
}
EUVIMED